L. Nee

Non‐invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study

J. Fallowfield, P. Hayes, J. Price, 2014, Liver international : official journal of the International Association for the Study of the Liver.

The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy.

P. Hayes, J. Price, B. Frier, 2011, Clinical radiology.

Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study

P. Hayes, J. Price, B. Frier, 2011, Diabetes Care.

Follow-up of incidental findings from abdominal ultrasound scans in an epidemiological study: the Edinburgh type 2 diabetes study

J. Price, R. Reynolds, M. Strachan, 2013 .

P2-202 Thiazolidinediones are associated with regression of hepatosteatosis in people with type 2 diabetes: the Edinburgh type 2 diabetes study

J. Price, J. Morling, M. Strachan, 2011, Journal of Epidemiology & Community Health.

Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study.

J. Fallowfield, J. Price, I. Guha, 2014, Journal of hepatology.

Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes

I. Deary, N. Sattar, J. Price, 2013, Diabetes Care.